Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
3/26/24 Praxis (PRAX) PRAX-628 for Seizure Disorders (Epilepsy) Subscribers Only Subscribers Only Subscribers Only
3/25/24 Axsome Therapeutics (AXSM) AXS-12 for Narcolepsy Subscribers Only Subscribers Only Subscribers Only
3/21/24 Roche (RHHBY) Enspryng for Myasthenia Gravis (MG) Subscribers Only Subscribers Only Subscribers Only
3/20/24 Acelyrin (SLRN) VB421 for Thyroid Eye Disease (TED) Subscribers Only Subscribers Only Subscribers Only
3/19/24 Merck (MRK) V116 for Pneumococcal (Streptococcus pneumoniae) Vaccines (Antibacterial) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
12/26/23 Subscribers Only Subscribers Only Trial Announcement - Initiation
12/31/23 Subscribers Only Subscribers Only Partnership - Acquisition Completion
02/16/24 Subscribers Only Subscribers Only Partnership - Acquisition Completion
02/16/24 Subscribers Only Subscribers Only Partnership - Acquisition Completion
02/29/24 Subscribers Only Subscribers Only Partnership - Acquisition Completion